Project Details
Description
A Phase 3, Multi-center, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy and Safety of SD-101 Cream in Patients with Epidermolysis Bullosa
| Status | Finished |
|---|---|
| Effective start/end date | 4/20/16 → 4/30/20 |
Funding
- SCIODERM, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.